E.B.L. van Dorst

1.9k citations

24 papers · 1.0k indexed · h-index 12

Impact in

Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments

Papers in ⓘ

Reproductive Medicine 9
- Ovarian cancer diagnosis and treatment 6
Epidemiology 8
- Cervical Cancer and HPV Research 4
- Nonmelanoma Skin Cancer Studies 3

Co-authors: Leon F.A.G. Massuger (5 shared papers)Marc van Beurden (6 shared papers)Neil K. Aaronson (4 shared papers)Eveline M. A. Bleiker (4 shared papers)Katja N. Gaarenstroom (6 shared papers)Heiðdís Valdimarsdóttir (4 shared papers)Marian J.E. Mourits (4 shared papers)Joanna B. Madalinska (3 shared papers)
Journals: Gynecologic Oncology (5 papers)Journal of Clinical Oncology (3 papers)Journal of the American Academy of Dermatology (1 paper)Clinical and Translational Radiation Oncology (1 paper)Psycho-Oncology (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

E.B.L. van Dorst

24 papers receiving 981 citations

Peers

Countries citing papers authored by E.B.L. van Dorst

Since Specialization

Citations

This map shows the geographic impact of E.B.L. van Dorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.B.L. van Dorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.B.L. van Dorst more than expected).

Fields of papers citing papers by E.B.L. van Dorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.B.L. van Dorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.B.L. van Dorst. The network helps show where E.B.L. van Dorst may publish in the future.

Co-authors

The 25 scholars most cited alongside E.B.L. van Dorst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.B.L. van Dorst Line = papers co-authored together E.B.L. van Dorst links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer Journal of Clinical Oncology ·Joanna B. Madalinska, Judith Hollenstein, Eveline M. A. Bleiker, Marc van Beurden, Heiðdís Valdimarsdóttir, Leon F.A.G. Massuger, Katja N. Gaarenstroom, Marian J.E. Mourits, René H.M. Verheijen, E.B.L. van Dorst, Hans van der Putten, Ko van der Velden, H. Boonstra, Neil K. Aaronson	2005	183
2	Sexual dysfunction and infertility as late effects of cancer treatment European Journal of Cancer Supplements ·Leslie R. Schover, Marleen van der Kaaij, E.B.L. van Dorst, Carien L. Creutzberg, É. Huyghe, Cecilie E. Kiserud	2014	157
3	The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy Journal of Clinical Oncology ·Joanna B. Madalinska, Marc van Beurden, Eveline M. A. Bleiker, Heiðdís Valdimarsdóttir, Judith Hollenstein, Leon F.A.G. Massuger, Katja N. Gaarenstroom, Marian J.E. Mourits, René H.M. Verheijen, E.B.L. van Dorst, Hans van der Putten, Ko van der Velden, H. Boonstra, Neil K. Aaronson	2006	157
4	A randomized clinical trial to compare two different approaches in women with chronic pelvic pain International Journal of Gynecology & Obstetrics ·AAW Peters, E.B.L. van Dorst, B Jellis, Esther J van Zuuren, Jos Hermans, JB Trimbos	1992	150
5	Changing Roles of Cadherins and Catenins during Progression of Squamous Intraepithelial Lesions in the Uterine Cervix American Journal Of Pathology ·Carla J. de Boer, E.B.L. van Dorst, J. Han van Krieken, Connie M. Jansen-van Rhijn, Sven O. Warnaar, Gert Jan Fleuren, Sergey V. Litvinov	1999	77
6	Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program Gynecologic Oncology ·H Beerman, E.B.L. van Dorst, Vibeke Kuenen‐Boumeester, Pancras C.W. Hogendoorn	2009	77
7	Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers Journal of Clinical Oncology ·Joanna B. Madalinska, Marc van Beurden, Eveline M. A. Bleiker, Heiðdís Valdimarsdóttir, Lottie A.C. Lubsen-Brandsma, Leon F.A.G. Massuger, Marian J.E. Mourits, Katja N. Gaarenstroom, E.B.L. van Dorst, Hans van der Putten, H. Boonstra, Neil K. Aaronson	2007	60
8	Vulvar Paget disease: A national retrospective cohort study Journal of the American Academy of Dermatology ·M. van der Linden, Maaike H.M. Oonk, Helena C. van Doorn, Johan Bulten, E.B.L. van Dorst, Guus Fons, Christianne Lok, Mariëtte I.E. van Poelgeest, Brigitte Slangen, Leon F.A.G. Massuger, Joanne A. de Hullu	2018	39
9	Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study European Journal of Cancer ·R. F. M. Vermeulen, Marc van Beurden, Jacobien M. Kieffer, Eveline M. A. Bleiker, Heiðdís Valdimarsdóttir, Leon F.A.G. Massuger, Marian J.E. Mourits, Katja N. Gaarenstroom, E.B.L. van Dorst, H.W.H.M. van der Putten, Neil K. Aaronson	2017	33
10	The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease JMIR Research Protocols ·M. van der Linden, K.A.P. Meeuwis, Colette van Hees, E.B.L. van Dorst, Johan Bulten, Tjalling Bosse, Joanna IntHout, Dorry Boll, B.F.M. Slangen, Manon van Seters, Marc van Beurden, Mariëtte I.E. van Poelgeest, Joanne A. de Hullu	2017	16
11	Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer Gynecologic Oncology ·Jammbe Musoro, Corneel Coens, Elfriede Greimel, Madeleine King, Mirjam A. G. Sprangers, Andy Nordin, E.B.L. van Dorst, Mogens Grøenvold, Kim Cocks, Galina Velikova, Hans‐Henning Flechtner, Andrew Bottomley	2020	15
12	Effects of a time out consultation with the general practitioner on cancer treatment decision‐making: a randomised controlled trial Psycho-Oncology ·I. A. A. Perfors, Eveline A. Noteboom, Niek J. de Wit, Elsken van der Wall, Ella Visserman, Thijs van Dalen, M.A.M.T. Verhagen, Arjen J. Witkamp, Ron Koelemij, Annebeth Flinterman, E.B.L. van Dorst, K. A. B. M. Pruissen-Peeters, Leon M.G. Moons, Franz M.N.H. Schramel, Marcel Th. M. van Rens, Miranda F. Ernst, Anne M. May, Charles W. Helsper	2020	12
13	Lymph node detection by MRI before and after a systematic pelvic lymphadenectomy Gynecologic Oncology ·Wenche M. Klerkx, A. Peter M. Heintz, W P Mali, G.A.P. de Kort, Takeshi Takahara, E.B.L. van Dorst, Petra H.M. Peeters	2009	9
14	Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective Gynecologic Oncology ·Kyra Bokkers, G. W. J. Frederix, Mary E. Velthuizen, Maaike A. van der Aa, Cornelis G. Gerestein, E.B.L. van Dorst, Joost G. Lange, J.A. Louwers, Wouter Koole, Ronald P. Zweemer, Margreet G.E.M. Ausems	2022	8
15	GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee Cancer Treatment Reviews ·Hannah Woopen, Jalid Sehouli, Alison Davis, Yeh Chen Lee, Paul A. Cohen, Annamaria Ferrero, Noreen Gleeson, Anuja Jhingran, Yusuke Kajimoto, J. Mayadev, Maria Pilar Barretina-Ginesta, Sudha Sundar, Nao Suzuki, E.B.L. van Dorst, Florence Joly	2022	7
16	Acceptance of Genetic Counseling and Testing in a Hospital‐Based Series of Patients with Gynecological Cancer Journal of Genetic Counseling ·Nicky Dekker, E.B.L. van Dorst, Rob B. van der Luijt, Mariëlle van Gijn, Marc van Tuil, Johan A. Offerhaus, Margreet G.E.M. Ausems	2012	6
17	Treatment decision‐making and the added value of the general practitioner: A qualitative exploration of cancer patients' perspectives European Journal of Cancer Care ·Eveline A. Noteboom, Sigrid C. J. M. Vervoort, Anne M. May, E.B.L. van Dorst, Anne S. R. van Lindert, Maarten W. van Elst, Rhodé M. Bijlsma, Elsken Wall, Niek J. de Wit, Charles W. Helsper	2021	4
18	Antigen size influences the type of glomerular pathology in chronic serum sickness Nephrology Dialysis Transplantation ·Pancras C.W. Hogendoorn, E.B.L. van Dorst, Sjoerd H. van der Burg, Jan A. Bruijn, Mohamed R. Daha, Ph. J. Hoedemaeker, Gert Jan Fleuren	1993	4
19	Radiotherapy as an alternative treatment for inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: Results of GROINSS-V II Gynecologic Oncology ·Ate Gj Van Der Zee, Brian M. Slomovitz, Allan Covens, Jacobus van der Velden, Joanne A. de Hullu, B.F.M. Slangen, E.B.L. van Dorst, W.J. Van Driel, Ralph H.M. Hermans, Ignace Vergote, David Nunns, C. Holland, David Cibula, Robert S. Mannel, Paul DiSilvestro, Diane Provencher, B.J. Monk, Maaike H.M. Oonk	2020	3
20	Age, pathology and CA-125 are prognostic factors for survival in patients with brain metastases from gynaecological tumours Clinical and Translational Radiation Oncology ·Steven Nagtegaal, Alexander Hulsbergen, E.B.L. van Dorst, Vasileios K. Kavouridis, Charissa Jessurun, Marike L. D. Broekman, Timothy R. Smith, Joost J.C. Verhoeff	2020	2

About E.B.L. van Dorst

E.B.L. van Dorst is a scholar working on Reproductive Medicine, Epidemiology, Oncology, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers), BRCA gene mutations in cancer (4 papers), Cervical Cancer and HPV Research (4 papers), Patient-Provider Communication in Healthcare (3 papers), Nonmelanoma Skin Cancer Studies (3 papers), Cancer survivorship and care (3 papers) and Cancer and Skin Lesions (3 papers). The work is most often cited by research in Reproductive Medicine (402 citations), Obstetrics and Gynecology (126 citations), Genetics (356 citations), Oncology (282 citations) and Public Health, Environmental and Occupational Health (215 citations). E.B.L. van Dorst has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Leon F.A.G. Massuger, Marc van Beurden, Neil K. Aaronson, Eveline M. A. Bleiker, Katja N. Gaarenstroom, Heiðdís Valdimarsdóttir, Marian J.E. Mourits, Joanna B. Madalinska, H. Boonstra and Leslie R. Schover. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Journal of the American Academy of Dermatology, Clinical and Translational Radiation Oncology and Psycho-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact